Celularity Inc

GX Acquisition Corp. II (Nasdaq: GXGX) was a blank-check company sponsored by GX Sponsor II LLC, with principals including former National Economic Council Director Gary Cohn and Gregg Polle, that completed its initial public offering in October 2020 with a focus on the healthcare and life sciences sector. The SPAC completed its business combination with Celularity Inc., a clinical-stage biopharmaceutical company developing placenta-derived allogeneic cell therapies for oncology, infectious disease, and degenerative conditions, in July 2021, with the combined entity subsequently trading on Nasdaq under the ticker CELU. A current report on Form 8-K was filed under the GXGX accession in December 2024. Sign up on SpacDesk for full filing history, deal timelines, and in-depth SPAC analytics on this transaction and thousands more.